0001870913-23-000007.txt : 20230919 0001870913-23-000007.hdr.sgml : 20230919 20230919171455 ACCESSION NUMBER: 0001870913-23-000007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230915 FILED AS OF DATE: 20230919 DATE AS OF CHANGE: 20230919 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shanmugam Muthusamy CENTRAL INDEX KEY: 0001870913 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31812 FILM NUMBER: 231264639 MAIL ADDRESS: STREET 1: C/O ANI PHARMACEUTICALS, INC. STREET 2: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001023024 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 582301143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 BUSINESS PHONE: 2186343500 MAIL ADDRESS: STREET 1: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 FORMER COMPANY: FORMER CONFORMED NAME: BIOSANTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19991228 FORMER COMPANY: FORMER CONFORMED NAME: BEN ABRAHAM TECHNOLOGIES INC DATE OF NAME CHANGE: 19991027 4 1 wk-form4_1695158086.xml FORM 4 X0508 4 2023-09-15 0 0001023024 ANI PHARMACEUTICALS INC ANIP 0001870913 Shanmugam Muthusamy C/O ANI PHARMACEUTICALS, INC. 210 MAIN STREET WEST BAUDETTE MN 56623 1 1 0 0 HEAD OF R&D, COO-NOVITIUM OPS 1 Common Stock 47407 D Common Stock 2023-09-15 4 S 0 16242 62.81 D 1116378 I Held by Esjay LLC Common Stock 2023-09-18 4 S 0 8425 61.64 D 1107953 I Held by Esjay LLC Common Stock 2023-09-19 4 S 0 25333 61.23 D 1082620 I Held by Esjay LLC Common Stock 5000 I Held by SS Pharma LLC The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $62.01 to $63.82, inclusive. The reporting person holds voting and dispositive power over the shares held by Esjay LLC. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $61.23 to $62.94, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $60.63 to $61.69, inclusive. The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC. /s/ Muthusamy Shanmugam, by attorney-in-fact Meredith W. Cook 2023-09-19